Rebate Reprieve For Generics And Biosimilars Added To Build Back Better Act

Generics Facing Shortages And Biosimilars Are Now Exempt From Rebate Scheme

 
• By Chloe Kent
  
Wooden letters on dark background
Select generics and biosimilars have been exempted from Build Back Better's rebate scheme • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Policy & Regulation

More from Generics Bulletin